Company Filing History:
Years Active: 2016-2017
Title: Inventor Spotlight: Paul W. Sauer
Introduction
Paul W. Sauer is a notable inventor based in Fremont, California. With a commendable portfolio of four patents, he has significantly contributed to the biotherapeutics field. His inventions, especially in the domain of daclizumab compositions, reflect his dedication to advancing healthcare solutions.
Latest Patents
Among his latest patents are innovative formulations related to daclizumab, particularly focused on DAC HYP compositions. The patents detail compositions suitable for subcutaneous administration and methods of manufacturing these critical therapeutic agents. This advancement demonstrates his commitment to enhancing the effectiveness and delivery of biologic medications.
Career Highlights
Paul currently works at AbbVie Biotherapeutics Inc., a prominent company in the biotechnology sector. His role involves extensive research and development, allowing him to utilize his skills to innovate and create valuable medical products for patients.
Collaborations
Throughout his career, Paul has collaborated with esteemed colleagues, including Taymar E. Hartman and John E. Burky. These partnerships highlight the importance of teamwork in the innovation process, where diverse insights contribute to successful inventions.
Conclusion
In summary, Paul W. Sauer's contributions to the field of biotherapeutics demonstrate his prowess as an inventor. With his focus on daclizumab and collaborations with talented professionals, he continues to pave the way for innovations that enhance patient care and outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.